5 out of every 100 adults in the U.S. has PTSD in any given year, according to data from the US Department of Veterans Affair.
Texas is expected to pass legislation to approve a comprehensive medical cannabis program in 2023, according to intel from a member of the Compassionate Use Program Working Group.
Texas is home to 1,435,787 veterans, accounting for 6.8% of the population.
TexasRx is committed to providing safe access to quality cannabis medicine to patients within the state of Texas. The company is committed to investing in scientific research to develop targeted medication for patients suffering from Post-Traumatic Stress Disorder.
The TexaRx medical library consists of hundreds of published, peer-reviewed papers on PTSD and mental health with a focus on veteran well-being.
TexaRx’s Medical Advisor is the PI on one of the only published clinical trials using cannabis to treat veterans with PTSD. We are committed to designing targeted cannabis medications for Veterans, First Responders, and other high-risk constituencies suffering from PTSD.
Copyright © 2023 TexaRx - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.